利马前列素

利马前列素（CAS 74397-12-9）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Limaprost is used for the improvement of various ischemic symptoms such as ulcer, pain and feeling of coldness associated with thromboangiitis obliterans as well as improvement of subjective symptoms (pain and numbness of lower legs) and gait ability associated with acquired lumbar spinal canal stenosis (in patients with bilateral intermittent claudication showing normal SLR test result).B - Blood and blood forming organs

同义词与商品名

Limaprost; 74397-12-9; Limaprostum; L02U804092; DTXSID701018146; RefChem:153454; DTXCID401476393; Limaprost alpha-cyclodextrin clathrate; ONO 1206; Limaprost [INN]; (E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]hept-2-enoic acid; OP-1206; ONO-1206; (2E,11-alpha,13E,15S,17S)-11,15-Dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic acid; (E)-7-((1R,2R,3R)-3-hydroxy-2-((3S,5S,E)-3-hydroxy-5-methylnon-1-en-1-yl)-5-oxocyclopentyl)hept-2-enoic acid; Limaprost (INN)

GHS 危害分类

Reported hazard statements	H300 (100%)

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

公开数据库对它的描述

Limaprost · CAS 74397-12-9 · C22H36O5. UNII L02U804092.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。